Hepion Pharmaceuticals Statistics
Total Valuation
HEPA has a market cap or net worth of 820,324. The enterprise value is 408,683.
| Market Cap | 820,324 |
| Enterprise Value | 408,683 |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HEPA has 11.62 million shares outstanding. The number of shares has increased by 5,826.83% in one year.
| Current Share Class | 11.62M |
| Shares Outstanding | 11.62M |
| Shares Change (YoY) | +5,826.83% |
| Shares Change (QoQ) | +2.58% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.24% |
| Float | 11.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.25 |
| P/TBV Ratio | 0.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.04 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.77, with a Debt / Equity ratio of 0.06.
| Current Ratio | 10.77 |
| Quick Ratio | 6.68 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.49 |
Financial Efficiency
Return on equity (ROE) is -628.46% and return on invested capital (ROIC) is -101.61%.
| Return on Equity (ROE) | -628.46% |
| Return on Assets (ROA) | -72.99% |
| Return on Invested Capital (ROIC) | -101.61% |
| Return on Capital Employed (ROCE) | -128.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -416,746 |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.78% in the last 52 weeks. The beta is 2.07, so HEPA's price volatility has been higher than the market average.
| Beta (5Y) | 2.07 |
| 52-Week Price Change | -99.78% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 50.06 |
| Average Volume (20 Days) | 25,237 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.35M |
| Pretax Income | -9.17M |
| Net Income | -9.17M |
| EBITDA | -4.33M |
| EBIT | -4.35M |
| Earnings Per Share (EPS) | -1.41 |
Balance Sheet
The company has 2.32 million in cash and 214,309 in debt, giving a net cash position of 2.11 million or 0.18 per share.
| Cash & Cash Equivalents | 2.32M |
| Total Debt | 214,309 |
| Net Cash | 2.11M |
| Net Cash Per Share | 0.18 |
| Equity (Book Value) | 3.32M |
| Book Value Per Share | 0.14 |
| Working Capital | 3.39M |
Cash Flow
| Operating Cash Flow | -4.09M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HEPA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5,826.83% |
| Shareholder Yield | -5,826.83% |
| Earnings Yield | -1,117.66% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 18, 2025. It was a reverse split with a ratio of 0.02.
| Last Split Date | Mar 18, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |